Defensins in the immunology of bacterial infections

Current Opinion in Immunology

Volumn 19, Issue 4, 2007, Pages 385-391

  Menendez, Alfredo ^a   Brett Finlay, B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSIN;

ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; IMMUNE RESPONSE; IMMUNOLOGY; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

ALPHA-DEFENSINS; ANIMALS; BACTERIAL INFECTIONS; BETA-DEFENSINS; CYTOKINES; DEFENSINS; HUMANS; IMMUNITY, NATURAL;

EID: 34548039239     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2007.06.008     Document Type: Review

References (72)

1. Ganz T., Selsted M.E., Szklarek D., Harwig S.S., Daher K., Bainton D.F., and Lehrer R.I. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 76 (1985) 1427-1435
2. Selsted M.E., Harwig S.S., Ganz T., Schilling J.W., and Lehrer R.I. Primary structures of three human neutrophil defensins. J Clin Invest 76 (1985) 1436-1439
3. Seebah S., Suresh A., Zhuo S., Choong Y.H., Chua H., Chuon D., Beuerman R., and Verma C. Defensins knowledgebase: a manually curated database and information source focused on the defensins family of antimicrobial peptides. Nucleic Acids Res 35 (2007) D265-D268
4. Bowdish D.M.E., Davidson D.J., and Hancock R.E.W. Immunomodulatory properties of defensins and cathelicidins. Curr Top Microbiol Immunol 306 (2006) 27-66. An excellent review on the topic.
5. Hill C.P., Yee J., Selsted M.E., and Eisenberg D. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 251 (1991) 1481-1485
6. Zimmermann G.R., Legault P., Selsted M.E., and Pardi A. Solution structure of bovine neutrophil beta-defensin-12: the peptide fold of the beta-defensins is identical to that of the classical defensins. Biochemistry 34 (1995) 13663-13671
7. Szyk A., Wu Z., Tucker K., Yang D., Lu W., and Lubkowski J. Crystal structures of human alpha-defensins HNP4, HD5 and HD6. Protein Sci 15 (2006) 2749-2760
8. Tang Y.Q., Yuan J., Osapay G., Osapay K., Tran D., Miller C.J., Ouellette A.J., and Selsted M.E. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 286 (1999) 498-502
9. Selsted M.E. Theta-defensins: cyclic antimicrobial peptides produced by binary ligation of truncated alpha-defensins. Curr Protein Pept Sci 5 (2004) 365-371
10. Harder J., Meyer-Hoffert U., Wehkamp K., Schwichtenberg L., and Schroder J.M. Differential gene induction of human beta-defensins (hBD-1, -2, -3 and -4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 123 (2004) 522-529
11. Sorensen O.E., Thapa D.R., Rosenthal A., Liu L., Roberts A.A., and Ganz T. Differential regulation of beta-defensin expression in human skin by microbial stimuli. J Immunol 174 (2005) 4870-4879
12. Schauber J., Dorschner R.A., Yamasaki K., Brouha B., and Gallo R.L. Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology 118 (2006) 509-519
13. Veldhuizen E.J., Hendriks H.G., Hogenkamp A., van Dijk A., Gaastra W., Tooten P.C., and Haagsman H.P. Differential regulation of porcine beta-defensins 1 and 2 upon Salmonella infection in the intestinal epithelial cell line IPI-2I. Vet Immunol Immunopathol 114 (2006) 94-102
14. Veerayutthwilai O., Byers M.R., Pham T.T., Darveau R.P., and Dale B.A. Differential regulation of immune responses by odontoblasts. Oral Microbiol Immunol 22 (2007) 5-13
15. Froy O. Regulation of mammalian defensin expression by Toll-like receptor-dependent and independent signalling pathways. Cell Microbiol 7 (2005) 1387-1397. An excellent review on the topic.
16. Tanabe H., Ayabe T., Bainbridge B., Guina T., Ernst R.K., Darveau R.P., Miller S.I., and Ouellette A.J. Mouse paneth cell secretory responses to cell surface glycolipids of virulent and attenuated pathogenic bacteria. Infect Immun 73 (2005) 2312-2320
17. •], this establishes a role for Nod proteins in the expression of defensins.
18. Kao C.Y., Chen Y., Thai P., Wachi S., Huang F., Kim C., Harper R.W., and Wu R. IL-17 markedly upregulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 173 (2004) 3482-3491
19. Ouhara K., Komatsuzawa H., Shiba H., Uchida Y., Kawai T., Sayama K., Hashimoto K., Taubman M.A., Kurihara H., and Sugai M. Actinobacillus actinomycetemcomitans outer membrane protein 100 triggers innate immunity and production of beta-defensin and the 18-kilodalton cationic antimicrobial protein through the fibronectin-integrin pathway in human gingival epithelial cells. Infect Immun 74 (2006) 5211-5220
20. ••].
21. Pivarcsi A., Nagy I., Koreck A., Kis K., Kenderessy-Szabo A., Szell M., Dobozy A., and Kemeny L. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human beta-defensin-2 in vaginal epithelial cells. Microbes Infect 7 (2005) 1117-1127
22. Mendez-Samperio P., Miranda E., and Trejo A. Mycobacterium bovis Bacillus Calmette-Guerin (BCG) stimulates human beta-defensin-2 gene transcription in human epithelial cells. Cell Immunol 239 (2006) 61-66
23. Zilbauer M., Dorrell N., Boughan P.K., Harris A., Wren B.W., Klein N.J., and Bajaj-Elliott M. Intestinal innate immunity to Campylobacter jejuni results in induction of bactericidal human beta-defensins 2 and 3. Infect Immun 73 (2005) 7281-7289
24. Liu L., Roberts A.A., and Ganz T. By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol 170 (2003) 575-580
25. Tsutsumi-Ishii Y., and Nagaoka I. Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. J Immunol 170 (2003) 4226-4236
26. Pioli P.A., Weaver L.K., Schaefer T.M., Wright J.A., Wira C.R., and Guyre P.M. Lipopolysaccharide-induced IL-1 beta production by human uterine macrophages upregulates uterine epithelial cell expression of human beta-defensin 2. J Immunol 176 (2006) 6647-6655
27. Moon S.K., Lee H.Y., Pan H., Takeshita T., Park R., Cha K., Andalibi A., and Lim D.J. Synergistic effect of interleukin 1 alpha on nontypeable Haemophilus influenzae-induced upregulation of human beta-defensin 2 in middle ear epithelial cells. BMC Infect Dis 6 (2006) 12
28. Howell M.D., Novak N., Bieber T., Pastore S., Girolomoni G., Boguniewicz M., Streib J., Wong C., Gallo R.L., and Leung D.Y. Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol 125 (2005) 738-745
29. ••].
30. Menzies B.E., and Kenoyer A. Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human beta-defensin 3 in skin keratinocytes. Infect Immun 74 (2006) 6847-6854
31. Sherman H., Chapnik N., and Froy O. Albumin and amino acids upregulate the expression of human beta-defensin 1. Mol Immunol 43 (2006) 1617-1623
32. Malik A.N., and Al-Kafaji G. Glucose regulation of beta-defensin-1 mRNA in human renal cells. Biochem Biophys Res Commun 353 (2007) 318-323
33. Boniotto M., Jordan W.J., Eskdale J., Tossi A., Antcheva N., Crovella S., Connell N.D., and Gallagher G. Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells. Antimicrob Agents Chemother 50 (2006) 1433-1441. This paper provides a detailed set of data showing the cytokine synthesis response of PBMC after exposure to hBD-1, -2 and -3. It also delineates differences in the cytokine expression patterns induced by these three defensins. These are interesting findings that may also contribute to explain the diversity of the defensins gene pool within humans and mice.
34. Niyonsaba F., Ushio H., Nakano N., Ng W., Sayama K., Hashimoto K., Nagaoka I., Okumura K., and Ogawa H. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 127 (2007) 594-604
35. Chen X., Niyonsaba F., Ushio H., Hara M., Yokoi H., Matsumoto K., Saito H., Nagaoka I., Ikeda S., Okumura K., et al. Antimicrobial peptides human beta-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur J Immunol 37 (2007) 434-444
36. Harada K., Ohba K., Ozaki S., Isse K., Hirayama T., Wada A., and Nakanuma Y. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree. Hepatology 40 (2004) 925-932
37. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., Shen B., Schaeffeler E., Schwab M., Linzmeier R., et al. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A 102 (2005) 18129-18134. A clear association between Crohn's disease of the ileum and a specific decrease of defensins synthesis had not been previously demonstrated. Here, the levels of HD-5 and HD-6 in intestinal specimens from diseased human subjects were analyzed and found to be lower than in non-diseased controls. The reduction on HD-5 and HD-6 was further exacerbated in some specimens also harboring mutations in the NOD2 gene. So far the clearest indication of defensins alteration in Crohn's. Also documents some fundamental differences between Crohn's disease of the ileum and the colon (see also annotation to Ref. [41]).
38. Rivas-Santiago B., Sada E., Tsutsumi V., Aguilar-Leon D., Contreras J.L., and Hernandez-Pando R. beta-Defensin gene expression during the course of experimental tuberculosis infection. J Infect Dis 194 (2006) 697-701
39. Valore E.V., Wiley D.J., and Ganz T. Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis. Infect Immun 74 (2006) 5693-5702
40. Yanagi S., Ashitani J., Imai K., Kyoraku Y., Sano A., Matsumoto N., and Nakazato M. Significance of human beta-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections. Clin Microbiol Infect 13 (2007) 63-69
41. Fellermann K., Stange D.E., Schaeffeler E., Schmalzl H., Wehkamp J., Bevins C.L., Reinisch W., Teml A., Schwab M., Lichter P., et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 79 (2006) 439-448. A genetic explanation to the hBD-2 deficiency observed in colonic Crohn's disease.
42. Elahi S., Buchanan R.M., Attah-Poku S., Townsend H.G., Babiuk L.A., and Gerdts V. The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets. Infect Immun 74 (2006) 2338-2352
43. Shu Q., Shi Z., Zhao Z., Chen Z., Yao H., Chen Q., Hoeft A., Stuber F., and Fang X. Protection against Pseudomonas aeruginosa pneumonia and sepsis-induced lung injury by overexpression of beta-defensin-2 in rats. Shock 26 (2006) 365-371
44. Moser C., Weiner D.J., Lysenko E., Bals R., Weiser J.N., and Wilson J.M. beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun 70 (2002) 3068-3072
45. Morrison G., Kilanowski F., Davidson D., and Dorin J. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect Immun 70 (2002) 3053-3060
46. Wilson C.L., Ouellette A.J., Satchell D.P., Ayabe T., Lopez-Boado Y.S., Stratman J.L., Hultgren S.J., Matrisian L.M., and Parks W.C. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286 (1999) 113-117
47. Pal S., Schmidt A.P., Peterson E.M., Wilson C.L., and de la Maza L.M. Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection. Immunology 117 (2005) 213-219
48. Salzman N.H., Ghosh D., Huttner K.M., Paterson Y., and Bevins C.L. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422 (2003) 522-526
49. ••]), a novel biological function of α- and θ-defensins is characterized. These defensins showed efficient inhibition of the enzymatic activity of two different types of bacterial toxins, and by virtue of it, protection from the toxins lethal effects, in vitro and in vivo. Breakthrough papers that expand the known antimicrobial repertoire of defensins.
50. Kim C., Slavinskaya Z., Merrill A.R., and Kaufmann S.H. Human alpha-defensins neutralize toxins of the mono-ADP-ribosyltransferase family. Biochem J 399 (2006) 225-229
51. Wang W., Mulakala C., Ward S.C., Jung G., Luong H., Pham D., Waring A.J., Kaznessis Y., Lu W., Bradley K.A., et al. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J Biol Chem 281 (2006) 32755-32764
52. Binks M.J., Fernie-King B.A., Seilly D.J., Lachmann P.J., and Sriprakash K.S. Attribution of the various inhibitory actions of the streptococcal inhibitor of complement (SIC) to regions within the molecule. J Biol Chem 280 (2005) 20120-20125
53. Fernie-King B.A., Seilly D.J., and Lachmann P.J. Inhibition of antimicrobial peptides by group A streptococci: SIC and DRS. Biochem Soc Trans 34 (2006) 273-275
54. Lukomski S., Hoe N.P., Abdi I., Rurangirwa J., Kordari P., Liu M., Dou S.J., Adams G.G., and Musser J.M. Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect Immun 68 (2000) 535-542
55. Nilsson M., Sorensen O.E., Morgelin M., Weineisen M., Sjobring U., and Herwald H. Activation of human polymorphonuclear neutrophils by streptolysin O from Streptococcus pyogenes leads to the release of proinflammatory mediators. Thromb Haemost 95 (2006) 982-990
56. Jin T., Bokarewa M., Foster T., Mitchell J., Higgins J., and Tarkowski A. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 172 (2004) 1169-1176
57. Palmer M. The family of thiol-activated, cholesterol-binding cytolysins. Toxicon 39 (2001) 1681-1689
58. Hamilton A., Popham D.L., Carl D.J., Lauth X., Nizet V., and Jones A.L. Penicillin-binding protein 1a promotes resistance of group B streptococcus to antimicrobial peptides. Infect Immun 74 (2006) 6179-6187
59. •]).
60. ••]).
61. ••]).
62. Mukherjee S., Keitany G., Li Y., Wang Y., Ball H.L., Goldsmith E.J., and Orth K. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312 (2006) 1211-1214
63. Mittal R., Peak-Chew S.Y., and McMahon H.T. Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signalling. Proc Natl Acad Sci U S A 103 (2006) 18574-18579
64. Fehr D., Casanova C., Liverman A., Blazkova H., Orth K., Dobbelaere D., Frey J., and Burr S.E. AopP, a type III effector protein of Aeromonas salmonicida, inhibits the NF-kappaB signalling pathway. Microbiology 152 (2006) 2809-2818
65. Arbibe L., Kim D.W., Batsche E., Pedron T., Mateescu B., Muchardt C., Parsot C., and Sansonetti P.J. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol 8 (2007) 47-56
66. Shelburne C.E., Coulter W.A., Olguin D., Lantz M.S., and Lopatin D.E. Induction of beta-defensin resistance in the oral anaerobe Porphyromonas gingivalis. Antimicrob Agents Chemother 49 (2005) 183-187
67. Stroinigg N., and Srivastava M.D. Modulation of toll-like receptor 7 and LL-37 expression in colon and breast epithelial cells by human beta-defensin-2. Allergy Asthma Proc 26 (2005) 299-309
68. Wencker M., and Brantly M.L. Cytotoxic concentrations of alpha-defensins in the lungs of individuals with alpha(1)-antitrypsin deficiency and moderate to severe lung disease. Cytokine 32 (2005) 1-6
69. Yamaguchi Y., Nagase T., Tomita T., Nakamura K., Fukuhara S., Amano T., Yamamoto H., Ide Y., Suzuki M., Teramoto S., et al. {beta}-defensin overexpression induces progressive muscle degeneration in mice. Am J Physiol Cell Physiol 292 (2007) C2141-C2149
70. Kraus D., and Peschel A. Molecular mechanisms of bacterial resistance to antimicrobial peptides. Curr Top Microbiol Immunol 306 (2006) 231-250
71. Crouch M.L., Becker L.A., Bang I.S., Tanabe H., Ouellette A.J., and Fang F.C. The alternative sigma factor sigma is required for resistance of Salmonella enterica serovar Typhimurium to anti-microbial peptides. Mol Microbiol 56 (2005) 789-799
72. Mandin P., Fsihi H., Dussurget O., Vergassola M., Milohanic E., Toledo-Arana A., Lasa I., Johansson J., and Cossart P. VirR, a response regulator critical for Listeria monocytogenes virulence. Mol Microbiol 57 (2005) 1367-1380